Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.

Tomida C, Yamagishi N, Nagano H, Uchida T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S.

Int J Oncol. 2018 Apr;52(4):1350-1362. doi: 10.3892/ijo.2018.4291. Epub 2018 Feb 28.

PMID:
29532881
2.

Reactive oxygen species upregulate expression of muscle atrophy-associated ubiquitin ligase Cbl-b in rat L6 skeletal muscle cells.

Uchida T, Sakashita Y, Kitahata K, Yamashita Y, Tomida C, Kimori Y, Komatsu A, Hirasaka K, Ohno A, Nakao R, Higashitani A, Higashibata A, Ishioka N, Shimazu T, Kobayashi T, Okumura Y, Choi I, Oarada M, Mills EM, Teshima-Kondo S, Takeda S, Tanaka E, Tanaka K, Sokabe M, Nikawa T.

Am J Physiol Cell Physiol. 2018 Jun 1;314(6):C721-C731. doi: 10.1152/ajpcell.00184.2017. Epub 2018 Mar 7.

3.

Regorafenib induces adaptive resistance of colorectal cancer cells via inhibition of vascular endothelial growth factor receptor.

Tomida C, Nagano H, Yamagishi N, Uchida T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S.

J Med Invest. 2017;64(3.4):262-265. doi: 10.2152/jmi.64.262.

4.

Antiangiogenic agent sunitinib induces epithelial to mesenchymal transition and accelerates motility of colorectal cancer cells.

Tomida C, Yamagishi N, Nagano H, Uchida T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S.

J Med Invest. 2017;64(3.4):250-254. doi: 10.2152/jmi.64.250.

5.

Capric Acid Up-Regulates UCP3 Expression without PDK4 Induction in Mouse C2C12 Myotubes.

Abe T, Hirasaka K, Kohno S, Tomida C, Haruna M, Uchida T, Ohno A, Oarada M, Teshima-Kondo S, Okumura Y, Choi I, Aoyama T, Terao J, Nikawa T.

J Nutr Sci Vitaminol (Tokyo). 2016;62(1):32-9. doi: 10.3177/jnsv.62.32.

6.

The malignant progression effects of regorafenib in human colon cancer cells.

Tomida C, Aibara K, Yamagishi N, Yano C, Nagano H, Abe T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S.

J Med Invest. 2015;62(3-4):195-8. doi: 10.2152/jmi.62.195.

7.

A novel myogenic function residing in the 5' non-coding region of Insulin receptor substrate-1 (Irs-1) transcript.

Nagano H, Yamagishi N, Tomida C, Yano C, Aibara K, Kohno S, Abe T, Ohno A, Hirasaka K, Okumura Y, Mills EM, Nikawa T, Teshima-Kondo S.

BMC Cell Biol. 2015 Mar 11;16:8. doi: 10.1186/s12860-015-0054-8.

8.

Chronic exposure of VEGF inhibitors promotes the malignant phenotype of colorectal cancer cells.

Tomida C, Yamagishi N, Aibara K, Yano C, Uchida T, Abe T, Ohno A, Hirasaka K, Nikawa T, Teshima-Kondo S.

J Med Invest. 2015;62(1-2):75-9. doi: 10.2152/jmi.62.75.

9.

[Space flight/bedrest immobilization and bone. Development of inhibitors for atrophy caused by unloading stress].

Kondo S, Arisa O, Kohno S, Abe T, Utsunomiya K, Nagano H, Suto T, Tomida C, Yamagishi N, Hirasaka K, Maita A, Okumura Y, Nikawa T.

Clin Calcium. 2012 Dec;22(12):1879-85. doi: CliCa121218791885. Review. Japanese.

PMID:
23187081
10.

Chronic renal failure with severe mesangiolysis in a hematopoietic stem cell transplant recipient.

Nishi H, Tomida C, Gotoh M, Yamagata K, Akiyama H, Shimokama T.

Ren Fail. 2006;28(6):519-22.

PMID:
16928623
11.

Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy.

Imai H, Hotta O, Yoshimura M, Konta T, Tsubakihara Y, Miyazaki M, Tomida C, Kobayashi M, Suzuki S, Shiiki H, Yamauchi A, Yokoyama H, Nose M.

Clin Exp Nephrol. 2006 Mar;10(1):40-54.

PMID:
16544177
12.

Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions.

Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, Arakawa Y, Shimizu Y, Tomida C, Hirayama K, Kobayashi M, Koyama A.

J Am Soc Nephrol. 2002 Jul;13(7):1816-23.

13.
14.

Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features.

Usui J, Yamagata K, Kai H, Outeki T, Yamamoto S, Muro K, Hirayama A, Yoh K, Tomida C, Hirayama K, Suzuki S, Kobayashi M, Nagata M, Koyama A.

Intern Med. 2001 Aug;40(8):697-702.

15.

[Recurrent retroperitoneal fibrosis associated with hyperglobulinemia].

Ohteki T, Tomida C, Goto M, Usui J, Muro K, Yamagata K, Koyama A.

Nihon Naika Gakkai Zasshi. 2000 Oct 10;89(10):2183-5. Japanese. No abstract available.

PMID:
11215135
16.

Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor.

Aoyagi K, Shahrzad S, Iida S, Tomida C, Hirayama A, Nagase S, Takemura K, Koyama A, Ohba S, Narita M, Cohen BD.

Kidney Int Suppl. 2001 Feb;78:S93-6.

PMID:
11168991
17.

Hemodialysis does not influence the peroxidative state already present in uremia.

Hirayama A, Nagase S, Gotoh M, Takemura K, Tomida C, Ueda A, Aoyagi K, Terao J, Koyama A.

Nephron. 2000 Dec;86(4):436-40.

PMID:
11124591
18.

Prevalence of Japanese dialysis patients with an A-to-G mutation at nucleotide 3243 of the mitochondrial tRNA(Leu(UUR)) gene.

Yamagata K, Tomida C, Umeyama K, Urakami Ki, Ishizu T, Hirayama K, Gotoh M, Iitsuka T, Takemura K, Kikuchi H, Nakamura H, Kobayashi M, Koyama A.

Nephrol Dial Transplant. 2000 Mar;15(3):385-8.

PMID:
10692525
19.

Creatol, an oxidative product of creatinine in hemodialysis patients.

Tomida C, Aoyagi K, Nagase S, Gotoh M, Yamagata K, Takemura K, Koyama A.

Free Radic Res. 2000 Jan;32(1):85-92.

PMID:
10625220
20.

Formation of guanidinosuccinic acid, a stable nitric oxide mimic, from argininosuccinic acid and nitric oxide-derived free radicals.

Aoyagi K, Akiyama K, Shahrzad S, Tomida C, Hirayama A, Nagase S, Takemura K, Koyama A, Ohba S, Narita M.

Free Radic Res. 1999 Jul;31(1):59-65.

PMID:
10489120
21.

Imaging of hydroperoxides in a rat glomerulus stimulated by puromycin aminonucleoside.

Aoyagi K, Akiyama K, Tomida C, Gotoh M, Hirayama A, Takemura K, Ueda A, Nagase S, Koyama A, Narita M.

Kidney Int Suppl. 1999 Jul;71:S153-5.

PMID:
10412763
22.

[A case of nephrotic syndrome associated with myasthenia gravis and malignant thymoma].

Tomida C, Yamagata K, Ishizu T, Nakajima M, Doi M, Kobayashi M, Koyama A.

Nihon Jinzo Gakkai Shi. 1999 Apr;41(2):77-82. Review. Japanese.

PMID:
10361423
23.

Intraperitoneal hyaluronan production in stable continuous ambulatory peritoneal dialysis patients.

Yamagata K, Tomida C, Koyama A.

Perit Dial Int. 1999 Mar-Apr;19(2):131-7.

PMID:
10357183
24.

Two cases of psoas abscess with discitis by methicillin-resistant Staphylococcus aureus as a complication of femoral-vein catheterization for haemodialysis.

Kikuchi S, Muro K, Yoh K, Iwabuchi S, Tomida C, Yamaguchi N, Kobayashi M, Nagase S, Aoyagi K, Koyama A.

Nephrol Dial Transplant. 1999 May;14(5):1279-81. No abstract available.

PMID:
10344380
25.

Biosynthesis of methylguanidine in the hepatic peroxisomes and the effect of the induction of peroxisomal enzymes by clofibrate.

Takemura K, Aoyagi K, Nagase S, Gotoh M, Hirayama A, Ueda A, Tomida C, Koyama A.

Nephron. 1998;78(1):82-7.

PMID:
9453408
26.

Favorable effect of hemodialysis on decreased serum antioxidant activity in hemodialysis patients demonstrated by electron spin resonance.

Nagase S, Aoyagi K, Hirayama A, Gotoh M, Ueda A, Tomida C, Kamezaki T, Nagai Y, Kikuchi H, Koyama A.

J Am Soc Nephrol. 1997 Jul;8(7):1157-63.

27.

Thiobarbituric acid reactive substances are increased in the subcutaneous fat tissue of patients with end-stage renal disease.

Gotoh M, Nagase S, Aoyagi K, Hirayama A, Takemura K, Ueda A, Tomida C, Kikuchi H, Koyama A.

Nephrol Dial Transplant. 1997 Apr;12(4):713-7.

PMID:
9140999
28.

Synthesis of guanidinosuccinate from argininosuccinate and reactive oxygen in vitro.

Aoyagi K, Nagase S, Tomida C, Takemura K, Akiyama K, Koyama A.

Enzyme Protein. 1996;49(4):199-204.

PMID:
9030886
29.

Decreased serum antioxidant activity of hemodialysis patients demonstrated by methylguanidine synthesis and microsomal lipid peroxidation.

Nagase S, Aoyagi K, Hirayama A, Gotoh M, Ueda A, Tomida C, Kikuchi H, Takemura K, Koyama A.

Nephron. 1996;74(3):555-60.

PMID:
8938680
30.

Increased lipid peroxidation by rat liver microsomes in experimental renal failure.

Nagase S, Aoyagi K, Gotoh M, Hirayama A, Tomida C, Shimozawa Y, Koyama A.

Nephron. 1996;74(1):204-8.

PMID:
8883041

Supplemental Content

Loading ...
Support Center